Twitxy Saved

George Ferman

Verified account This account is verified. Learn more

@Helios_Movement

Ex PT // Scaling health stores // Helped thousands of people improve their health // Not medical advice healthlibrary.substack.com
Elevate your health šŸ‘‰ fitandball.gumroad.com/l/georgesystem… Joined January 2022
281 Following 1.2M Followers 48K Posts

Latest posts 5

George Ferman Verified account @Helios_Movement
Both too little and too much zinc can harm your essential fatty acid conversion.

Even a marginal zinc deficiency (6mg/day with some phytates) can slash FADS1 activity by 29% in just two weeks.

But the activity and the associated lipid changes did not fully normalize on 10 mg/day but did on 25 mg/day.

So in general keep in mind that a baseline amount of zinc (8-15mg/day usually) is required for the Δ5 and Δ6 desaturase enzymes.

But too much can also significantly decrease desaturase activity.

This is why ridiculously high-dose zinc supplements can give you symptoms similar to those of following a diet low in O3s when used for prolonged time periods.

It's not just about harming the zinc:copper ratio.

fitandball.gumroad.com/l/brain20/v30
0 replies 0 reposts 23 likes 2.9K views View on X
George Ferman Verified account @Helios_Movement
Too much free time in this day and age, where "information" is everywhere, is a curse.

You will never apply anything and end up with a bunch of theories that sound good in your own head but don't actually help you (they usually end up harming you).

It's very common for example for someone to spend HUNDREDS of hours studying a topic and still not have a clear picture of what will actually improve his situation.

Gathering facts is not the same as having (or creating) a highly efficient roadmap to get to your destination as fast as possible.

It might feel productive, especially if you are young, but you are doomed to fail sooner or later.

Let's say that you have a gut issue for example and want to solve it.

If you search for general advice such as "how to heal the gut" you are fucked.

The trends and ultimate level of bs that's out there will have you leaving poorer and sicker sooner than you think.

No.

If you have a gut issue that's not something obvious like Crohn's, for example, you start by understanding how your digestion works to begin with.

Do you know how your body digests protein for example? Carbs? Fats?

What does it need to even do these processes?

If not, then your first job is to provide the things it needs.

After you've covered these (most people's idea of covering these are not eating processed foods, zinc carnosine, glutamine and BPC-157 at best so most people in reality need to spend more time in this step) you move on to certain tests and highly targeted approaches based on the results.

It's the same with everything.
Let's say that you want to get back into shape at 45.

Your first job is to cover the undeniable requirements everyone's body needs to add muscle and keep body fat somewhat low, some of which are for example:

-The right dose of stimuli
-The tools that help us adapt to that stimulus (hormones, macronutrients, micronutrients, sleep etc)
-Progressively increasing the dose without getting injured

You can not argue with these and proceed to do "military-based training for people over 50" only to end up injured and skinny fat.

You get the idea by now (hopefully).

If not here it is one more time:

-Gathering facts is useless at best.
Stop wasting your time on it.

Most likely you will link random facts together like Skinner's pigeons and end up one shotting yourself (all of us do it if we are not careful)

-Learn how to properly approach your problems or get help

fitandball.gumroad.com/l/brain20/v30
0 replies 1 reposts 28 likes 3.1K views View on X
George Ferman Verified account @Helios_Movement
God this will do like 0 likes but some of you need to hear it.

If you SWEAR by a certain approach and you GET negative results over and over, just stop.

Does this sound obvious? Good.

Now for a lot of people in the health space this is not obvious because they are basically gambling with the health reserves they have.

If they spent 20K on something related to their business and they got negative results they would SCREAM ā€œSCAM SCAM SCAMā€.

But this doesn’t happen with their own health.
0 replies 1 reposts 23 likes 3.8K views View on X
George Ferman Verified account @Helios_Movement
"No man you don't understand the pressure is too much, i need a drink in order to relax".

You don't need alcohol.
You need to work on your GABAergic systems.

The brain contains a vast neural architecture where billions of cells continuously exchange information.

This complex signaling is driven by neurotransmitters, the molecular messengers responsible for cellular communication.

So by attempting to decode neurotransmitters, we are attempting to map the specific language the brain uses to send instructions and process our thoughts and emotions.

Overall, in case you are new here, neurotransmitters are chemical substances that neurons release to send signals across synapses, the tiny gaps between nerve cells.

These molecules are categorized based on their effects.

We have:

-Excitatory neurotransmitters that increase the likelihood of a neuron firing an action potential.

-Inhibitory neurotransmitters that decrease the likelihood of a neuron firing, providing a calming effect.

-Modulatory neurotransmitters that influence the overall activity of groups of neurons, modulating their function over time.

GABA is the one that counterbalances the excitatory actions of glutamate and helps maintain the excitation-inhibition (E/I) balance, which is essential for proper brain function.

Reduced GABAergic tone frequently disrupts this equilibrium and leads to neuronal hyperexcitability (and a widespread over-excitation in different brain regions overall), which is a state implicated in numerous neuropsychiatric and neurological disorders.

This is why if you experience symptoms and conditions such as:

-Generalized anxiety disorder

-Panic disorder

-Racing thoughts

-Sleep-onset insomnia and fragmented sleep architecture

-Muscle tension and physical restlessness

-Heightened startle response

-Bipolar disorder

-ADHD

-Emotional reactivity / irritability

-Difficulty focusing / sensory overload

-Major Depressive Disorder

-Autism Spectrum Disorder (ASD)

-Schizophrenia

-Epilepsy (various syndromes)

-Obsessive-Compulsive Disorder (OCD)

-Chronic pain and central sensitization

-Fibromyalgia

-Alcohol withdrawal syndrome

-Post-traumatic stress disorder (PTSD)

then you likely need to explore GABA.

Of course, low GABA tone/dysfunctional GABA signaling is rarely the sole cause of any of these and it usually interacts with inflammation, genetics, stress, and a few other factors besides glutamate excess.

But many of these symptoms/conditions improve when GABA tone is supported through lifestyle, nutrition, or targeted therapies.

So it’s a valuable puzzle piece towards resolving any of these.

Overall, if GABA was irrelevant, benzodiazepines wouldn’t be so popular and abused or GABAB receptor-mediated inhibition wouldn’t be so dysregulated in depressed adolescents (especially the ones with histories of suicidal behavior).

Now GABA (γ-aminobutyric acid) is a non-proteinogenic amino acid(*) that serves as the primary inhibitory neurotransmitter in the mammalian CNS and was isolated and identified as a major component of brain tissue by Eugene Roberts and Sam Frankel around 1950.

(*) Proteinogenic amino acids (the 20 standard ones + a few others like selenocysteine) are used by ribosomes to build proteins according to the genetic code.

GABA is non-proteinogenic, so it is not incorporated into proteins during protein synthesis.

It has a different structure (the amino group is on the gamma carbon instead of the alpha carbon), so it cannot be used in the standard translation process.

So GABA functions almost exclusively as a signaling molecule (neurotransmitter) and metabolic intermediate, not as a structural building block of proteins.

This is why it is rarely just called an ā€œamino acidā€ without the qualifier ā€œnon-proteinogenicā€ in scientific literature.

It mediates inhibitory neurotransmission at roughly 20–50% of all synapses in the brain with particularly dense representation in (*)the cerebral cortex, hippocampus, amygdala, basal ganglia, and spinal cord.

You may find the range 30%-40% in some textbooks, but usually, most agree that’s roughly 20%-50%.

(*) Meta-analyses of magnetic resonance spectroscopy (MRS) studies show significantly reduced GABA concentrations in these exact key brain regions in individuals with active major depression, anxiety disorders, panic disorders and ASD.
Discover more
scientific
science

Check Voting Info

GABAergic neurons and terminals are also dense in several other regions worth naming individually, since each maps onto a specific function:

-The thalamus (relays sensory and motor information to the cortex).

-The hypothalamus (regulates hormones, body temperature, hunger, and the stress response).

-The brainstem (controls breathing, heart rate, sleep, and other vital automatic functions).

-The cerebellum (coordination, balance, posture, and motor learning)

-The olfactory bulb (processes smell).

-The retina (processes visual information before it reaches the brain).

-The superior colliculus (coordinates eye and head movements in response to visual stimuli).

-The inferior colliculus (processes auditory information).

-The vestibular nuclei (maintain balance and spatial orientation).

-The suprachiasmatic nucleus or SCN (controls circadian rhythm and the sleep-wake cycle).

This widespread distribution is why GABA touches nearly every major aspect of brain function, not just mood and anxiety:

-Attention

-Memory

-Movement

-Sensory processing

-Pain perception

-Motor coordination

-The sleep-wake cycle

….are all downstream of it.

In MDD for example postmortem studies show decreased expression of GAD67 and parvalbumin in prefrontal interneurons (we will talk about both of these in a moment).

Low GABA basically impairs prefrontal regulation of limbic structures, so the person has a very hard time getting out of negative thought loops.

Notably, successful antidepressant treatment (pharmacological or neuromodulatory) often normalizes cortical GABA levels, suggesting state-dependent rather than purely trait-related changes.

In schizophrenia, postmortem and imaging data also reveal deficits in GABAergic interneurons (particularly parvalbumin-positive cells that we’ll briefly talk about in a moment) and altered GAD expression, contributing to impaired gamma oscillations and sensory gating and in epilepsy, loss of inhibitory tone, whether through reduced GAD activity, interneuron loss, or chloride homeostasis disruption, lowers the seizure threshold.

Also, in generalized anxiety disorder, positron emission tomography (PET) studies demonstrate reduced benzodiazepine-binding site density in the amygdala, prefrontal cortex, and insula, consistent with diminished GABAA receptor availability and benzodiazepine sensitivity.

There also seems to be reduced GABAA-benzodiazepine binding sites in the insular cortex of individuals with panic disorder and PTSD.

All of these make sense even if we didn’t have any studies ont them, since dense GABAergic innervation of the amygdala, prefrontal cortex, and hippocampus enables top-down control of fear and stress responses. So the hypo-inhibition experienced in MDD, GAD and so on, permits excessive amygdala reactivity to neutral or mildly threatening stimuli for example, producing persistent worry, autonomic hyperarousal, and even panic attacks.

At the cellular level, GABA released into the synaptic cleft binds primarily to two receptor classes:

Ionotropic GABAA receptors

These are ligand-gated ion channels (pentameric structures made of five protein subunits).

When GABA binds, they open and allow chloride ions (Cl⁻) to flow into the neuron.

In mature neurons, this causes hyperpolarization (the inside of the cell becomes more negative), making it harder for the neuron to fire.

To put a number on that: a neuron typically rests at around āˆ’70 mV.

Once chloride rushes in, the membrane potential drops further, often to around āˆ’80 mV or lower, while the threshold needed to fire an action potential sits at roughly āˆ’55 mV.

So a hyperpolarized neuron needs a much bigger excitatory push just to get back to where it can fire at all.

This is what ā€œraising the barā€ for glutamate-driven signals actually looks like in voltage terms.

They can also produce shunting inhibition, which dampens excitatory signals even without major voltage change, and by keeping the membrane well below threshold for long enough, GABA effectively prevents the voltage sensors on nearby sodium channels from activating in the first place, blocking the propagation of a signal before it can spread.

Some of their key features include:

Phasic inhibition: Fast, brief bursts at synapses (mainly synaptic receptors).

Tonic inhibition: Steady, low-level background inhibition (extrasynaptic receptors, often containing Ī“ subunits).

There are 19 different subunits (α1–6, β1–4, γ1–3, Ī“, etc. with rarer ones like ε, Īø, Ļ€, and ρ1–3 also part of the full family).

The most common combination is α1β2γ2. Subunit composition determines:

α1 → Strong sedation and anticonvulsant effects (target of many sleeping pills).

α2 & α3 → Anxiolytic (anti-anxiety) and muscle-relaxant effects.

α5 → Contributes more to cognitive processes, particularly learning and memory, rather than sedation or anxiolysis.

Ī“-containing → Tonic inhibition, seizure threshold, and sensitivity to alcohol/neurosteroids. These Ī“ subunits typically pair specifically with α4 or α6 subunits.

Benzodiazepines, barbiturates, alcohol, and neurosteroids (like allopregnanolone) act here as positive allosteric modulators, enhancing GABA’s effect.

Metabotropic GABAB receptors.

These are G-protein-coupled receptors (metabotropic), working more slowly but with longer-lasting effects.

They exist as heterodimers (GABAB1 + GABAB2).

When GABA binds to GABAB receptors, it triggers two main effects depending on where the receptor is located:

1. Presynaptic GABAB receptors (on the sending neuron)

These act as autoreceptors or heteroreceptors.

Activation → inhibits voltage-gated calcium channels (specifically N-type and P/Q-type Ca²⁺ channels).

Result: Less calcium enters the presynaptic terminal when an action potential arrives.

Because calcium is required for neurotransmitter vesicles to fuse and release their contents, less calcium = less neurotransmitter release.

This includes:

Reduced release of glutamate (excitatory) → overall calming effect.

Reduced release of GABA itself (negative feedback on the inhibitory neuron).

This is a form of presynaptic inhibition that dampens both excitatory and inhibitory signaling over a longer timescale.

2. Postsynaptic GABAB receptors (on the receiving neuron)

Activation couples to G-proteins that open inwardly rectifying potassium channels (GIRK channels).

Potassium ions (K⁺) flow out of the cell.

Result: The inside of the neuron becomes more negative → slow hyperpolarization.

This makes the postsynaptic neuron less excitable for a longer period (hundreds of milliseconds to seconds), producing a slow, sustained inhibitory effect.

So GABAB receptors are important for:

Regulating network oscillations

Pain modulation

Mood stability

Preventing excessive excitation over longer time scales

Baclofen is a GABAB agonist used for muscle spasticity and sometimes alcohol dependence.

This variety of GABAA receptor subtypes allows the brain to fine-tune inhibition for different needs:

Fast, precise control (phasic)

Steady background calm (tonic)

Region-specific effects (amygdala for fear, hippocampus for memory, cortex for thinking)

This diversity also explains why drugs like benzodiazepines can be both helpful (anxiety relief) and problematic (sedation, tolerance, dependence, profoundly cooked brain etc).

It’s also worth flipping the picture for a second: this whole article has been about what happens when GABA tone is too low, but too much inhibition causes its own problems:

-Excessive sedation

-Reduced alertness

-Slower reaction times

-Impaired coordination (ataxia)

-Cognitive slowing

-Memory difficulties

-Reduced motivation

The goal was never to max out GABA activity as if more is automatically better; it’s to keep the E/I balance in a healthy range, since inhibition that’s too strong is just as disruptive as inhibition that’s too weak.

What’s also interesting is that in the fetal and newborn brain, high intracellular chloride makes GABAA activation excitatory rather than inhibitory.

This ā€œGABA switchā€ is crucial for brain development and disruptions here are linked to autism, epilepsy, and other neurodevelopmental conditions overall.

Now, GABA is synthesized in a single enzymatic step from glutamate by the enzyme glutamate decarboxylase (GAD).

Two major isoforms exist, each with distinct localization and functional roles:

GAD67 (encoded by GAD1, ~67 kDa): Primarily cytosolic and constitutively active.

It maintains basal GABA levels for tonic inhibition and is especially critical during brain development.

GAD65 (encoded by GAD2, ~65 kDa): Membrane-associated and often found in an inactive apo-form near synaptic vesicles.

It is rapidly activated in response to neuronal activity and supports phasic, on-demand GABA release.

The decarboxylation reaction (Glutamate + H⁺ → GABA + COā‚‚) requires pyridoxal 5′-phosphate (P5P), the bioactive form of vitamin B6, as an essential cofactor.

P5P forms a Schiff base with a lysine residue in the active site of GAD, enabling the reaction.

Newly synthesized GABA is packaged into synaptic vesicles by the vesicular GABA transporter (VGAT / SLC32A1), which uses a proton gradient.

Upon arrival of an action potential and calcium influx, vesicles undergo exocytosis, releasing GABA into the synaptic cleft.

Clearance occurs rapidly to terminate signaling and recycle the transmitter.

This is mediated by high-affinity, sodium- and chloride-dependent GABA transporters.

The predominant transporter is GAT1 (SLC6A1), expressed on both presynaptic GABAergic terminals and astrocytes. GAT1 accounts for ~70–85% of GABA reuptake.

A smaller contribution comes from GAT3 (SLC6A11) on astrocytes.šŸ“·
Once inside the cell, GABA is primarily metabolized through the GABA shunt, a bypass of the tricarboxylic acid (TCA) cycle that tightly links inhibitory neurotransmission to energy metabolism:

GABA transaminase (GABA-T / ABAT), a mitochondrial enzyme, transaminates GABA with α-ketoglutarate to produce succinic semialdehyde and glutamate (which can be reused for GABA synthesis). This step also requires P5P as a cofactor.

Succinic semialdehyde dehydrogenase (SSADH / ALDH5A1) then oxidizes succinic semialdehyde to succinate, generating NADH in the process.

Succinate enters the TCA cycle, supporting ATP production.

The net result of the GABA shunt is the conversion of α-ketoglutarate to succinate while recycling glutamate and contributing ~10–20% of neuronal energy under basal conditions (more during high activity).

This pathway links inhibitory neurotransmission directly to cellular energy metabolism.

So GABA counterbalances glutamate’s excitatory signals.

By opening chloride channels (primarily via GABAA receptors), it produces rapid hyperpolarization, or shunting inhibition, that decreases the probability of neuronal firing and helps maintain balanced brain activity.

Now GABAergic interneurons, including parvalbumin-, somatostatin-, and chandelier-positive cells, provide precise temporal and spatial control over pyramidal neuron firing.

They sculpt cortical rhythms (such as gamma oscillations), sharpen sensory processing, and support higher-order cognition.

It’s totally normal at this point to think ā€œwhat the fuck does that even meanā€ so here’s an analogy we’ve previously used.

Imagine that your brain is a huge classroom full of kids (that represent neurons) who all want to talk at once.

GABAergic interneurons are like the teachers who keep everything under control.

There are three special teachers:

Parvalbumin teachers are the fastest and loudest teachers, telling everyone to be quiet.

Somatostatin teachers are the more patient ones, walking around and gently calming down the kids who are getting too excited on their own desks (that represent dendrites).

Chandelier teachers decide exactly when a kid is allowed to speak.

Now when it comes to being medically/biochemically accurate:

Parvalbumin-positive (PV+) interneurons are fast-spiking cells that provide powerful perisomatic inhibition, wrapping around the cell body and proximal dendrites of pyramidal neurons.

Their rapid kinetics enable them to synchronize large populations of pyramidal cells, generating high-frequency gamma oscillations (30–80 Hz).

These oscillations are critical for attention, working memory, sensory binding, and conscious perception.

PV+ interneurons are particularly vulnerable to oxidative stress and are frequently impaired in schizophrenia, autism spectrum disorder, and epilepsy.

Somatostatin-positive (SST+) interneurons primarily target distal dendrites of pyramidal neurons.

By modulating dendritic calcium spikes and excitatory input integration, they regulate synaptic plasticity, dendritic computation, and the gating of information flow.

SST+ cells are key players in feedback inhibition and are involved in shaping contextual and emotional processing in the hippocampus and cortex.

Chandelier cells, a specialized subtype of GABAergic interneuron, form distinctive ā€œcartridgeā€ synapses exclusively onto the axon initial segment of pyramidal neurons, the exact site where action potentials are generated.

This strategic positioning allows chandelier cells to exert powerful, high-fidelity control over pyramidal neuron output, acting as a final ā€œgatekeeperā€ for neuronal firing.

Their dysfunction, whether through reduced numbers, impaired function, or altered synaptic strength, is a common feature in conditions characterized by E/I imbalance, including schizophrenia, autism, epilepsy, and major depressive disorder.

Now just like with all neurotransmitters, GABA signaling extends well beyond the central nervous system.

For example, in the pancreas, β-cells synthesize and co-release GABA along with insulin.

Once released, GABA acts on neighboring α-cells to inhibit glucagon secretion and exerts autocrine effects that promote β-cell survival and proliferation.

Or in the gastrointestinal tract, enteric neurons and certain gut bacteria, particularly strains of Lactobacillus and Bifidobacterium (Lactobacillus brevis, Bifidobacterium dentium, and others) synthesize GABA via their own GAD homologues which influences gut motility, secretion, and communication along the gut-brain axis via vagal and systemic pathways.

Also dysbiosis is associated with lower GABA levels and increased anxiety-like behavior in animal models and probiotic interventions sometimes raise brain GABA.

Additionally, many immune cells (including T cells and macrophages) express functional GABAA and GABAB receptors, through which GABA exerts anti-inflammatory and immunoregulatory effects by suppressing pro-inflammatory cytokines and promoting regulatory immune responses.
Now unfortunately, there are no routine clinical blood tests for brain GABA levels (plasma GABA correlates poorly with central concentrations).

Assessment therefore relies on:

Detailed symptom pattern recognition.

Response to empirical GABA-supportive interventions (magnesium, P5P, l-theanine and everything that we’ll discuss later).

Advanced imaging (MRS, PET) or EEG if for some reason are available, typically in research or specialty settings.

Exclusion of mimics/ruling out conditions that can produce overlapping symptoms, including thyroid dysfunction, vitamin B12 or folate deficiency, sleep apnea, and substance use or withdrawal.

Genetic testing for variants in GAD1/GAD2, SLC6A1 (GAT1), GABR subunit genes, or KCC2/NKCC1 can alsp be informative.

But in general, modern lifestyles challenge GABAergic function through multiple converging mechanisms such as:

Chronic stress/glucocorticoid exposure (which downregulates GAD and GABAA receptor expression)

Micronutrient deficiencies

Neuroinflammation, mitochondrial impairment

Sleep disruption/harmed circadian health

Repeated exposure to GABAergic modulators such as alcohol that produce tolerance and rebound hyperexcitability.

Mitochondrial dysfunction

Hormonal imbalances

For example, GABA is not made from scratch, it is synthesized directly from glutamate via GAD as we saw in the previous article.

But the precursor pool of glutamate is generated inside the mitochondria.

So if mitochondria are damaged, they cannot export enough glutamate to the cytosol and without the raw building blocks, neurons cannot synthesize adequate amounts of GABA.

In general, GABA synthesis (GAD), vesicular loading (VGAT), reuptake (GAT1, Na⁺/K⁺-ATPase dependent), and degradation (mitochondrial GABA-T and SSADH) are all energy-intensive.

Besides this, pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) suppress GAD activity, impair GAT1 trafficking, promote GABAA receptor internalization, plus reactive oxygen and nitrogen species damage GABAergic interneurons, which are particularly vulnerable due to high metabolic demand and relatively low antioxidant capacity.

Then, in cases of hormonal issues such as low progesterone, high estrogen or hypothyroidism (underactive thyroid), the enzymatic activity required to synthesize GABA drops.

Thyroid hormones (Tā‚ƒ and Tā‚„) act as direct regulators of GAD activity.

Estrogen upregulates glutamate.

Your body converts progesterone into a neurosteroid called allopregnanolone (ALLO) that cts as a positive allosteric modulator for GABA-A.

This is partly why women on hormonal birth control are more likely to experience symptoms such as anxiety compared to non-users.

Then when it comes to micronutrient deficiencies the classic examples are B6, magnesium and zinc.

P5P is the essential cofactor for both GAD65 and GAD67.

So a deficiency impairs the glutamate-to-GABA conversion, rapidly lowering GABA synthesis.

Mg²⁺ acts as a positive allosteric modulator of GABAA receptors and supports GAD activity.

Hypomagnesemia increases neuronal excitability by reducing GABAergic inhibition and enhancing NMDA receptor function.

Zinc modulates GABAA receptor subtypes and transporter function.

Deficiencies in taurine, antioxidants, or B vitamins can of course further compromise GABA synthesis.

Taurine for example acts as a weak agonist and positive allosteric modulator of GABAA receptors.

It enhances GABA’s calming effects, especially at extrasynaptic receptors that mediate tonic inhibition.

Plus it has strong antioxidant and anti-inflammatory properties so it protects GABAergic interneurons (especially parvalbumin-positive cells) from oxidative stress and excitotoxicity.

So low taurine makes these vulnerable neurons more likely to become damaged or dysfunctional.

It also helps regulate intracellular chloride levels (via effects on NKCC1 and KCC2 transporters) which is important for keeping GABA inhibitory rather than excitatory and maintains cell volume and mitochondrial function in neurons and astrocytes.

Also, low taurine can lead to cellular stress that impairs GABA synthesis (GAD activity) and reuptake (GAT1 function).

Then, prolonged glucocorticoid exposure downregulates GAD67 expression, reduces GABAA receptor subunit mRNA (particularly α2 and γ2), and decreases parvalbumin interneuron density in the hippocampus and prefrontal cortex.

This creates a vicious cycle: low GABA → heightened stress reactivity → further HPA activation.

When it comes to things such as alcohol, its acute potentiation of GABAA receptors (especially Ī“-containing) might produce anxiolysis initially, but chronic exposure causes receptor downregulation, internalization, and tolerance.

Also obviously, chronic use of bezons leads to GABAA receptor desensitization, subunit switching (↓γ2, ↑α4), and dependence.

What’s also interesting is that heavy metals, pesticides (organophosphates, neonicotinoids), and certain environmental chemicals can also directly inhibit GAD or damage GABAergic neurons.

After addressing these, there other tools you can consider adding to support GABA that can be found here:
fitandball.gumroad.com/l/brain20/v30
George Ferman Verified account @Helios_Movement 12h
If you are an entrepreneur, trader, or executive, you understand the concept of asymmetric risk.

You look for investments where the downside is strictly capped, but the upside is virtually limitless.

Now, let's apply that exact math to your primary wealth-generating asset: your mind.

Think about your last major mental mistake.

Maybe it was a bad trade executed during a mid-afternoon energy crash.

Maybe it was a critical client email you put off.

What did that single moment of cognitive fatigue actually cost you?

For some people in high-stakes industries, a single foggy day can cost tens of thousands in lost revenue or missed opportunities.

That is the hidden tax of poor brain health.

Read the thread for more or go here for the entire formula:
fitandball.gumroad.com/l/brain20/v30

"I actually am in fact a CEO and want to know more".
Well, here's an angle that you might not have thought of before.

Despite what most people might assume about your environment, YOU, know that you don't necessarily need less pressure in order to be more productive.

Or, even if you do, let's be honest: removing it isn't always realistic.

You can temporarily take some responsibilities off your plate, go on a trip, have dinner at a nice restaurant, or grab a beer with a friend.

But it won't last long.

Shortly after that, the same responsibilities will come knocking on your door.

The project you assigned to your team won't go exactly as you initially expected.

Someone will take longer than anticipated to finish a task.

Someone will have personal problems that affect their ability to stay engaged.

Someone will ask you questions that seem so obvious you'll start wondering how they managed to get hired in the first place.

And the project itself?

It will have problems you didn't consider at the beginning.

What initially looked like a straightforward idea will inevitably turn out to involve more variables, more decisions, and more work than you anticipated.

And this isn't necessarily a bad thing.

It simply means that pressure is part of the process.

Which is why eliminating it isn't the goal, and you know that.

If that were the goal, you'd probably have chosen a different path a long time ago.

You continue because you understand that the pressure, the decisions, and the responsibilities sometimes pay off.

And when they do, the results can be worth everything that went into producing them.

But if removing the pressure isn't the goal, what is?
It's knowing how to handle it.

It's being able to walk into a meeting after someone on your team has made a costly mistake, sit down, assess what happened, and calmly work out an alternative.

It's understanding that not everything will go as expected and that reality will always introduce variables you couldn't account for, while remaining confident in your ability to find a solution.

It's being able to take an urgent call that could jeopardize months of work, process the information, evaluate your options, and make the best decision available to you at that moment.

Without allowing frustration, anxiety, or a thousand competing thoughts to interfere with the decision itself.

And it's being able to do all of this without carrying the entire working day back home with you.

That's a lot to handle.

And if you don't have someone you can share the burden with, or someone you can consult when things go wrong, the pressure can become particularly difficult to manage.

You might start withdrawing from the people around you.

You might become increasingly irritable, impatient, or emotionally unavailable.

You might find yourself replaying conversations, anticipating problems, and thinking about work long after you've left the office.

Or you might start relying on external ways to switch off.

Perhaps a few drinks, distractions, or other forms of escape after work become your way of temporarily shutting down the constant stream of thoughts.

And while these things might provide temporary relief, they don't necessarily improve your ability to deal with the situations that caused the pressure in the first place.

The responsibilities remain.

The problems remain.

And the next morning, you're back where you started.

The pressure might not be going anywhere, but your response to it can change.

Think about the difference between entering a room full of problems while stressed, mentally scattered, and already anticipating everything that could go wrong, compared with entering that exact same room calm, focused, and able to process whatever information comes your way.

The circumstances haven't changed.

The people haven't changed.

The problems haven't changed.

But your ability to deal with them has.

And truth be told, you probably know this already.

Which is why you've likely looked into ways to improve your focus, regulate your stress responses, manage your mood, and maintain your cognitive performance under pressure.

You might have experimented with supplements, different routines, breathing techniques, meditation, exercise, or other approaches.

Perhaps some of them helped.

But you might also have noticed that the results weren't always consistent, or that something that seemed to work initially eventually stopped producing the same effects.

At some point, you may have started looking into the chemistry behind these processes.

And that's where neurotransmitters enter the picture.

You've probably come across at least a few of these:

Dopamine: Involved in motivation, reward processing, goal-directed behavior, learning, and the ability to sustain effort toward something you want to achieve.

Norepinephrine: Involved in alertness, vigilance, attention, working memory, and how your brain responds to demanding or potentially threatening situations.

Serotonin: Involved in mood regulation, emotional processing, sleep, appetite, and several aspects of behavioral control.

Epinephrine: Involved in the body's fight-or-flight response, increasing cardiovascular output, mobilizing energy, and preparing you to respond to immediate demands.

These chemicals influence many of the functions that matter when you're managing a business.

Your ability to concentrate on a complex problem.

Your willingness to pursue a difficult objective.

Your capacity to remain attentive during a long meeting.

Your emotional response when something goes wrong.

Your ability to regulate frustration instead of immediately reacting to it.

Your level of alertness throughout the day.

And your ability to transition from a demanding working day into a state where you can actually relax.

Of course, none of these functions is controlled by a single neurotransmitter.

They depend on interactions between several signaling systems, brain regions, receptors, and physiological processes.

Nevertheless, these four are particularly relevant to the discussion.

And if you've looked into ways to influence them, you've probably encountered countless supplements, tools, and recommendations claiming to increase or decrease their levels.

Some focus on dopamine.

Others target serotonin or norepinephrine.

Some recommend specific nutrients, while others focus on stimulating or suppressing particular receptors.

But here's the part most of them leave out:

The enzymes responsible for producing these neurotransmitters in the first place.

You can spend a considerable amount of time looking for ways to influence dopamine, norepinephrine, or epinephrine.

But how much attention have you paid to the biochemical machinery responsible for manufacturing them?

Because neurotransmitters don't simply appear when your brain needs them.

Your body has to produce them through a series of chemical reactions, each involving specific enzymes, substrates, cofactors, and regulatory mechanisms.

And when one of these steps is impaired, the consequences can extend further downstream.

Let's take dopamine as an example.

Before your body can produce dopamine, it needs an amino acid called tyrosine.

Tyrosine is supplied through dietary protein and serves as the starting material for the production of dopamine, norepinephrine, and epinephrine.

But converting tyrosine into these chemicals requires an enzyme called tyrosine hydroxylase (TH).

This enzyme catalyzes the conversion of tyrosine into L-DOPA.

And here's why it deserves your attention.

TH is considered the rate-limiting enzyme in catecholamine synthesis.

In other words, it represents one of the main control points determining how quickly your body can produce these neurotransmitters.

Its activity depends on several factors, including:

Tetrahydrobiopterin (BH4), an essential cofactor.

Iron, which is required at the enzyme's active site.

Oxygen, which participates in the reaction.

Phosphorylation, which helps regulate its catalytic activity.

Feedback mechanisms that prevent excessive dopamine production.

So even before we get to dopamine itself, we already have an enzyme whose activity depends on a number of interconnected processes.

And this is only the first step.

Once TH converts tyrosine into L-DOPA, another enzyme takes over.

It's called aromatic L-amino acid decarboxylase (AADC).

AADC converts L-DOPA into dopamine, but it also participates in serotonin synthesis by converting 5-HTP into serotonin.

Its activity depends on pyridoxal-5-phosphate (PLP), the active form of vitamin B6.

This means that the same enzyme participates in the production of two different neurotransmitters.

And that's not where the pathway ends.

Dopamine is also the precursor of norepinephrine.

To convert it, your body relies on another enzyme called dopamine beta-hydroxylase (DBH).

DBH operates inside secretory vesicles and requires copper and vitamin C to carry out its reaction.

If its activity is compromised, dopamine may be available while its conversion into norepinephrine becomes less efficient.

Finally, norepinephrine can be converted into epinephrine through an enzyme called phenylethanolamine N-methyltransferase (PNMT).

This reaction depends on a methyl donor called S-adenosylmethionine (SAM).

And SAM availability is connected to methionine metabolism, ATP, and the recycling of homocysteine, a process that involves folate and vitamin B12.

In other words, even the final step of epinephrine production depends on a wider metabolic network.

Each enzyme has its own requirements, regulatory mechanisms, and potential bottlenecks.

And each one deserves to be understood in the context of the entire pathway, rather than treated as an isolated chemical reaction.

Of course, this doesn't mean that poor concentration, stress, irritability, or low motivation automatically indicate an enzyme deficiency.

Nor does it mean that taking more of a particular vitamin will necessarily increase neurotransmitter production.

The point is that neurotransmitter levels and signaling depend on much more than the supplements people commonly recommend.

You need to understand how these chemicals are produced, what their synthesis depends on, how their activity is regulated, and what happens when one of the underlying processes is disrupted.

And that's precisely what we'll be examining.

Because if you're trying to understand how to support your cognitive performance, emotional regulation, and ability to respond to demanding situations, looking at the neurotransmitters alone gives you an incomplete picture.

You also need to understand the enzymes behind them.

fitandball.gumroad.com/l/brain20/v30
View quoted post on X